Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Insights and Forecast to 2028

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Buspirone
1.2.3 Bupropion
1.2.4 Testosterone
1.2.5 Flibanserin
1.2.6 Bremelanotide
1.2.7 Cognitive Behavior Therapy
1.3 Market by Application
1.3.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2017-2028)
2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Region
2.2.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Dynamics
2.3.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Trends
2.3.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
2.3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
2.3.4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue
3.1.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue (2017-2022)
3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue
3.4 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio
3.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2021
3.5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players Head office and Area Served
3.6 Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
3.7 Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Type
4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2023-2028)
5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Application
5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
6.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
6.2.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
6.2.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
6.2.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
6.3.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
6.3.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
6.3.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
6.4.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022)
6.4.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
7.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
7.2.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
7.3.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
7.4.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
8.2.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
8.3.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region
8.4.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
9.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
9.2.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
9.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
9.3.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
9.4 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
9.4.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
10.2.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
10.3.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
10.4.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Company Details
11.1.2 AMAG Pharmaceuticals Business Overview
11.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
11.1.5 AMAG Pharmaceuticals Recent Developments
11.2 Allergan, Plc.
11.2.1 Allergan, Plc. Company Details
11.2.2 Allergan, Plc. Business Overview
11.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
11.2.5 Allergan, Plc. Recent Developments
11.3 Ivix LLX
11.3.1 Ivix LLX Company Details
11.3.2 Ivix LLX Business Overview
11.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
11.3.5 Ivix LLX Recent Developments
11.4 EndoCeutics, Inc.
11.4.1 EndoCeutics, Inc. Company Details
11.4.2 EndoCeutics, Inc. Business Overview
11.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
11.4.5 EndoCeutics, Inc. Recent Developments
11.5 Emotional Brain BV
11.5.1 Emotional Brain BV Company Details
11.5.2 Emotional Brain BV Business Overview
11.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
11.5.5 Emotional Brain BV Recent Developments
11.6 S1 Biopharma, Inc.
11.6.1 S1 Biopharma, Inc. Company Details
11.6.2 S1 Biopharma, Inc. Business Overview
11.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
11.6.5 S1 Biopharma, Inc. Recent Developments
11.7 Sprout Pharmaceuticals, Inc.
11.7.1 Sprout Pharmaceuticals, Inc. Company Details
11.7.2 Sprout Pharmaceuticals, Inc. Business Overview
11.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
11.7.5 Sprout Pharmaceuticals, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Buspirone
Table 3. Key Players of Bupropion
Table 4. Key Players of Testosterone
Table 5. Key Players of Flibanserin
Table 6. Key Players of Bremelanotide
Table 7. Key Players of Cognitive Behavior Therapy
Table 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2017-2022)
Table 12. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2023-2028)
Table 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
Table 15. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
Table 16. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
Table 17. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Players (2017-2022)
Table 20. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2021)
Table 21. Ranking of Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
Table 25. Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2017-2022)
Table 29. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2023-2028)
Table 31. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Application (2017-2022)
Table 33. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Application (2023-2028)
Table 35. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 65. AMAG Pharmaceuticals Company Details
Table 66. AMAG Pharmaceuticals Business Overview
Table 67. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 68. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
Table 69. AMAG Pharmaceuticals Recent Developments
Table 70. Allergan, Plc. Company Details
Table 71. Allergan, Plc. Business Overview
Table 72. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 73. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
Table 74. Allergan, Plc. Recent Developments
Table 75. Ivix LLX Company Details
Table 76. Ivix LLX Business Overview
Table 77. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 78. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
Table 79. Ivix LLX Recent Developments
Table 80. EndoCeutics, Inc. Company Details
Table 81. EndoCeutics, Inc. Business Overview
Table 82. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 83. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
Table 84. EndoCeutics, Inc. Recent Developments
Table 85. Emotional Brain BV Company Details
Table 86. Emotional Brain BV Business Overview
Table 87. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 88. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
Table 89. Emotional Brain BV Recent Developments
Table 90. S1 Biopharma, Inc. Company Details
Table 91. S1 Biopharma, Inc. Business Overview
Table 92. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 93. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
Table 94. S1 Biopharma, Inc. Recent Developments
Table 95. Sprout Pharmaceuticals, Inc. Company Details
Table 96. Sprout Pharmaceuticals, Inc. Business Overview
Table 97. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 98. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
Table 99. Sprout Pharmaceuticals, Inc. Recent Developments
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Buspirone Features
Figure 3. Bupropion Features
Figure 4. Testosterone Features
Figure 5. Flibanserin Features
Figure 6. Bremelanotide Features
Figure 7. Cognitive Behavior Therapy Features
Figure 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2021 VS 2028
Figure 9. Hospitals Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered
Figure 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region: 2021 VS 2028
Figure 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2021
Figure 17. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2021
Figure 19. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
Figure 21. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
Figure 22. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Country (2017-2028)
Figure 23. United States Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
Figure 27. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
Figure 28. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Country (2017-2028)
Figure 29. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Region (2017-2028)
Figure 39. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Country (2017-2028)
Figure 49. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Country (2017-2028)
Figure 55. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
Figure 59. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
Figure 60. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
Figure 61. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
Figure 62. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
Figure 63. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
Figure 64. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs